• Zeacann

Second round of AUT postgraduate Medicinal Cannabis Science paper utilises Zeacann expertise

Auckland University of Technology has again partnered with Zeacann to present a second round of their Medicinal Cannabis Science paper - the world's first post-graduate course in medicinal cannabis science.


Zeacann co-founder Chris Fowlie originally proposed the course to course leader Dr Ali Seyfoddin, who quickly grasped the opportunity to help train New Zealand's next generation of cannabis scientists.


For the inaugural course in 2020, Chris Fowlie helped develop and present curriculum for the Masters-level paper, sharing his expertise and network of industry partners.


AUT are now running the course again, in the second semester of 2021, and will again use course content developed by Zeacann's Chris Fowlie.


The course further cements Zeacann's research partnership with AUT, and we are delighted to help train the next generation of highly skilled cannabis researchers, breeders, technicians, developers and horticulturalists.


The course begins in semester 2, starting July 2021.


What the Science of Medicinal Cannabis course includes:

• Introduction to medicinal cannabis: History and legislation

• Current New Zealand legislative framework for the cultivation and use of medicinal cannabis

• The New Zealand medicinal cannabis scheme

• Botanical aspects of cannabis, including breeding and cultivation of cannabis cultivars

• Pre-formulation processing of herbal cannabis

• Cannabinoid pharmacology, cannabinoid receptors and the endocannabinoid system

• The chemistry of cannabinoids

• Medicinal uses of cannabis

• Extraction of cannabinoids

• Analysis of cannabinoids

• Cannabinoid delivery systems and dosing


Course details

Introduction to Medicinal Cannabis (BIOL803) [PDF, 136.6 KB]


Chris Fowlie, chief executive of ZeaCann, has previously noted the medicinal cannabis industry needs qualified staff with relevant expertise.


"This course will teach the skills needed to work in the field. Hundreds of new jobs are expected to be created, with the potential for medicinal cannabis exports to rival those of wine or wool.


"We're excited to help AUT deliver this course as part of our ongoing research partnership. Zeacann will leverage our extensive network of industry partners to provide practical content and access to global experts and key industry players."


ZeaCann's research and production partners include manufacturers, growers, processors, botanists, pharmacies, laboratory and extraction equipment suppliers, and a network of contract growers spanning all cultivation styles.



More information:

AUT partners with Zeacann to present Medicinal Cannabis Science paper

AUT offers medicinal cannabis paper




36 views0 comments